Originally presented 4 June 2020
Posttraumatic stress disorder (PTSD) is a prevalent and debilitating disorder. Although effective treatments for PTSD have been identified, there are barriers to both delivering and receiving these treatments. From the patient perspective, the treatments are time consuming (e.g., number of sessions and between session assignments), which accounts for high dropout rates (i.e., 36%). From the provider perspective, the treatments involve substantial training to be able to effectively deliver and the time required to prepare for treatment sessions serves as an additional barrier (Finley et al., 2015). Written Exposure Therapy (WET) represents an alternative, evidence-based PTSD treatment approach that is efficient and associated with low treatment dropout rates (e.g., less than 10%). Moreover, WET has been found to be non-inferior relative to the more time intensive Cognitive Processing Therapy (CPT), with significantly lower dropout rates relative to CPT. This webinar describes the development of WET, efficacy findings support its use, and provides recommendation for the types of patients for whom WET might be most appropriate.
- Appraise barriers to implementing first-line PTSD treatment approaches.
- Differentiate critical elements of written exposure therapy.
- Evaluate the efficacy data for written exposure therapy.
- Distinguish situations when it is appropriate to use written exposure therapy.